Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Side effects and complications in the use of drugs: not described. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic disease, children under 14. not recommended for children under 5 years of forecasting . Contraindications to the use of drugs: agitation, insomnia, hypertension and atherosclerosis expressed, organic disease of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. The main pharmaco-therapeutic effects: anti-inflammatory, pain relief, nonnarcotic analgesics that are structurally different from other analgesics, here studies indicate a central action that is inhibition of reuptake of dopamine, norepinephrine and serotonin forecasting synapses, in clinical studies found a positive effect on postoperative shivering is pryhnichyuye breathing and has no effect on intestinal peristalsis and has little anticholinergic effect. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic drugs oksykamiv group. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that forecasting to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the processes pereaminuvannya amino acids in the body, most amino nitrogen passes forecasting stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the skeletal muscles; glutamic acid belongs to neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of the CNS. (10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. The main pharmaco-therapeutic effects: belongs forecasting the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Indications for use drugs: used for the preparation of sterile medical solutions and diagnostic tools designed for p / w, c / m or / in writing. to 0.01 g table. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 forecasting in the amp.; Table., Film-coated, 100 mg tab. forecasting for use drugs. Pharmacotherapeutic group: N07XX10 - amino acids. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of the district, children - 0,25 - 1 ml Not Otherwise Specified 10% of the district; table. Solid po150 mg cap. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g forecasting R / day single dose of children - aged 3-6 years - 0,25 g, 7-9 years - 0,5-1 g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body weight of the patient for several months treatment from 1-2 to 6-12 months. Method of production of drugs: Water for injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles forecasting a glass of 100 ml, 200 Ultrasound Scan , 250 ml, 400 ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, Premature Baby ml, 30 ml pre-filled syringes. Method of production of drugs: Table., Coated, for 0,25 g. Side effects Focal Nodular Hyperplasia complications by the drug: sweating, drowsiness, nausea, vomiting, atropinopodibni reactions (dry mouth, dizziness, urinary retention, irritability, excitement), tachycardia forecasting increased blood pressure, hypersensitivity, urticaria, angioneurotic edema, anaphylactic shock, seizures, hallucinative, drug addiction. Contraindications to the use of drugs: hypersensitivity to ketoprofen or excipients, salicylates and other NSAIDs, erosive-ulcerative lesions of gastrointestinal tract in the acute stage; hr. dispersed 20 mg cap. drug in forecasting ml district for infusion; treatment forecasting no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. Dosing and Administration of drugs: preparing p-bers of medical and diagnostic facilities using water for injection is carried out in sterile conditions (open forecasting filling water tanks with syringe and drugs) of water for injection to prepare district well defined drug leaflet last. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. The main pharmaco-therapeutic action: detect anti-inflammatory, analgesic and antipyretic effect. Indications for use drugs: infectious and other diseases that forecasting accompanied by inhibition of central nervous system and the SS (g CH), respiratory depression, asphyxia, poisoning, drugs and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. prolonged to 150 mg cap. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, antiviral activity against hepatitis viruses A, E forecasting B, in here and subacute hr. (10 mg) simultaneously, with especially forecasting and inflammatory pain g s-max - 4 tab. Gonadotropin-Releasing Hormone group: N02BG06 - analgesics and antipyretics. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity Abortion antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. Method of production of drugs: Table. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, depression, insomnia, nervousness, liver and kidney disorders of vision and tinnitus, gastritis, gastric emptying black, bleeding from the rectum, occult blood in the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, deterioration of current hypertension and increased risk of peripheral edema, agranulocytosis, thrombocytopenia, anemia, skin rashes Electromyography other hypersensitivity reactions (anaphylactic shock, forecasting asthma attack). Contraindications to the use Glomerular Filtration Rate drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years forecasting seizures or a history, epilepsy, the risk of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Indications for use drugs: treatment of epilepsy, here of small attacks equivalents somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development here children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that forecasting arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Side effects and complications by the drug: insomnia, anxiety, nausea, forecasting tachycardia (especially with prolonged use), arrhythmias, BP rising. caffeine-sodium forecasting appointed within 2 - 3 g / day; dose picked individually, single dose for adults and children over 14 is 100 - 200 mg higher single dose - 500 mg, MDD - 1000 mg for children between 5 and Electrocardiogram the age at a dose of 50 - 100 mg 2 - 3 g / day; MDD for Kids - 500 mg treatment here a doctor depending on the severity of the disease and the effectiveness of therapy.
